*Treatment of HER2-positive metastatic or locally recurrent unresectable breast cancer in combination with trastuzumab and docetaxel, in patients who have not received previous anti-HER2 therapy or chemotherapy:* BY IV INF: Adults: Initial dose is 840mg IV INF over 60 min, followed by 420 mg IV INF...
| Brand Name | Manufacturer / Company | Available Pack Sizes & Price | Action |
|---|---|---|---|
| PERJETA | 🏢 ROCHE |
Inj 420 mg/14 ml 127500.00:
Rs.150000.00
|
View Details → |